In the area of dystonia treatment, we continue to provide botulinum toxin injections to our patients while training physicians to perform these injections. For patients with blepharospasm, we have been evaluating the efficacy of various types of non-invasive brain stimulation. Low frequency repetitive TMS, theta burst stimulation and tDCS have been compared. We are also conducting therapeutic trials in blepharospasm of a cream that has an action similar to botulinum toxin. Past studies from our group have shown that certain rehabilitation techniques, such as motor training and sensory training can be therapeutic. We are trying to develop other methods of rehabilitation that might be more efficacious. New treatments are needed for essential tremor. One promising agent is 1-octanol and its metabolite, 1-octanoic acid, which we continue to develop. We have characterized the pharmacokinetics and compared the efficacy of different formulations in a dose escalation and cross-over study in patients with essential tremor. Most recently, we have been conducting trials with 1-octanoic acid, seeking the maximum tolerated dose.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Zip Code
Haubenberger, Dietrich; Nahab, Fatta B; Voller, Bernhard et al. (2014) Treatment of essential tremor with long-chain alcohols: still experimental or ready for prime time? Tremor Other Hyperkinet Mov (N Y) 4:
Slobounov, Semyon; Bazarian, Jeff; Bigler, Erin et al. (2014) Sports-related concussion: ongoing debate. Br J Sports Med 48:75-6
Srivanitchapoom, Prachaya; Pandey, Sanjay; Hallett, Mark (2014) Drooling in Parkinson's disease: a review. Parkinsonism Relat Disord 20:1109-18
Abrams, Steven B; Hallett, Mark (2013) Clinical utility of different botulinum neurotoxin preparations. Toxicon 67:81-6
Haubenberger, Dietrich; McCrossin, Gayle; Lungu, Codrin et al. (2013) Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study. Neurology 80:933-40
Lungu, C; Considine, E; Zahir, S et al. (2013) Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy. Eur J Neurol 20:515-8
Zeuner, Kirsten E; Knutzen, Arne; Pedack, Lucas et al. (2013) Botulinum neurotoxin treatment improves force regulation in writer's cramp. Parkinsonism Relat Disord 19:611-6
Kranz, Gottfried; Shamim, Ejaz A; Lin, Peter T et al. (2013) Long-term depression-like plasticity of the blink reflex for the treatment of blepharospasm. Mov Disord 28:498-503
Naumann, Markus; Dressler, Dirk; Hallett, Mark et al. (2013) Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders. Toxicon 67:141-52
Mak, Margaret; Hallett, Mark (2013) Effect of cued training on motor evoked potential and cortical silent period in people with Parkinson's disease. Clin Neurophysiol 124:545-50

Showing the most recent 10 out of 18 publications